新型影像学方法在系统性炎症疾病心脏表现中的应用：美国心脏病学会科学声明
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement.
机构信息
Division of Cardiology, Brigham and Women's Hospital, Harvard University, Boston, Massachusetts, USA.
Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA.
出版信息
J Am Coll Cardiol. 2023 Nov 28;82(22):2128-2151. doi: 10.1016/j.jacc.2023.09.819.
Abstract
Derangements in the innate and adaptive immune responses observed in systemic inflammatory syndromes contributes to unique elevated atherosclerotic risk and incident cardiovascular disease. Novel multimodality imaging techniques may improve diagnostic precision for the screening and monitoring of disease activity. The integrated application of these technologies lead to earlier diagnosis and noninvasive monitoring of cardiac involvement in systemic inflammatory diseases that will aid in preclinical studies, enhance patient selection, and provide surrogate endpoints in clinical trials, thereby improving clinical outcomes. We review the common cardiovascular manifestations of immune-mediated systemic inflammatory diseases and address the clinical and investigational role of advanced multimodality cardiac imaging.
摘要
全身性炎症综合征中观察到的先天和适应性免疫反应失调导致独特的动脉粥样硬化风险升高和心血管疾病事件。新型多模态成像技术可能提高疾病活动筛查和监测的诊断精度。这些技术的综合应用可实现全身性炎症性疾病心脏受累的早期诊断和非侵入性监测，有助于临床前研究，增强患者选择，并在临床试验中提供替代终点，从而改善临床结局。我们回顾了免疫介导的全身性炎症性疾病的常见心血管表现，并探讨了先进的多模态心脏成像的临床和研究作用。
相似文献
1
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement.
J Am Coll Cardiol. 2023 Nov 28;82(22):2128-2151. doi: 10.1016/j.jacc.2023.09.819.
2
Imaging Risk in Multisystem Inflammatory Diseases.
JACC Cardiovasc Imaging. 2019 Dec;12(12):2517-2537. doi: 10.1016/j.jcmg.2018.06.033. Epub 2019 Mar 13.
3
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
J Nucl Cardiol. 2017 Dec;24(6):2043-2063. doi: 10.1007/s12350-017-1070-1.
4
The years 2015-2016 in the European Heart Journal-Cardiovascular Imaging. Part I.
Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1092-1098. doi: 10.1093/ehjci/jex192.
5
Multi-modality cardiac imaging in advanced chronic kidney disease.
Echocardiography. 2019 Jul;36(7):1372-1380. doi: 10.1111/echo.14413. Epub 2019 Jun 17.
6
Multimodality imaging: Bird's eye view from the 2019 American College of Cardiology Scientific Sessions.
J Nucl Cardiol. 2020 Apr;27(2):410-416. doi: 10.1007/s12350-019-02016-z. Epub 2020 Jan 23.
7
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association.
Circulation. 2023 Oct 17;148(16):1271-1286. doi: 10.1161/CIR.0000000000001174. Epub 2023 Sep 21.
8
Integrating Multimodal Imaging in Clinical Practice: The Importance of a Multidisciplinary Approach.
Rev Esp Cardiol (Engl Ed). 2016 May;69(5):477-9. doi: 10.1016/j.rec.2016.01.019. Epub 2016 Apr 3.
9
The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis.
Curr Med Imaging Rev. 2019;15(1):10-20. doi: 10.2174/1573405614666180522074320.
10
Applications of PET-MR Imaging in Cardiovascular Disorders.
PET Clin. 2020 Oct;15(4):509-520. doi: 10.1016/j.cpet.2020.06.007. Epub 2020 Jul 21.
引用本文的文献
1
CAD at the Intersection of Cardiology and Rheumatology: Focus on Cardiovascular Imaging.
Methodist Debakey Cardiovasc J. 2025 Aug 12;21(4):65-75. doi: 10.14797/mdcvj.1646. eCollection 2025.
2
The Perivascular Fat Attenuation Index: Bridging Inflammation and Cardiovascular Disease Risk.
J Clin Med. 2025 Jul 4;14(13):4753. doi: 10.3390/jcm14134753.
3
Innovating the Gold Standard: The Emerging Role of Echocardiographic Stress Testing in the Classification, Stratification, and Prognostication in Pulmonary Vascular Disease.
Curr Cardiol Rep. 2025 Jun 23;27(1):100. doi: 10.1007/s11886-025-02242-7.
4
Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Psoriasis and Psoriatic Arthritis for Dermatologists, Rheumatologists, and Primary Care Physicians by the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network.
J Psoriasis Psoriatic Arthritis. 2025 May 28:24755303251337020. doi: 10.1177/24755303251337020.
5
Retinal optical coherence tomography angiography (OCTA) biomarkers of cardiovascular disease: a review article.
Eye (Lond). 2025 May 14. doi: 10.1038/s41433-025-03780-8.
6
Cardiovascular disease risk in psoriatic disease: mechanisms and implications for clinical practice.
Curr Opin Rheumatol. 2025 Jul 1;37(4):261-268. doi: 10.1097/BOR.0000000000001092. Epub 2025 May 13.
7
Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics.
ESC Heart Fail. 2025 Aug;12(4):2669-2690. doi: 10.1002/ehf2.15307. Epub 2025 Apr 24.
8
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial.
Circulation. 2025 May 20;151(20):1467-1476. doi: 10.1161/CIRCULATIONAHA.124.072756. Epub 2025 Apr 21.
9
Clinical Risk Predictors for Abnormal Left Ventricular and Atrial Function in Lupus Erythematosus.
J Am Soc Echocardiogr. 2025 Jun;38(6):486-497. doi: 10.1016/j.echo.2025.03.001. Epub 2025 Mar 8.
10
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities.
J Scleroderma Relat Disord. 2025 Jan 20:23971983241313096. doi: 10.1177/23971983241313096.
本文引用的文献
1
Atherosclerosis in Systemic Lupus Erythematosus.
Curr Atheroscler Rep. 2023 Nov;25(11):819-827. doi: 10.1007/s11883-023-01149-4. Epub 2023 Sep 28.
2
Acute cardiovascular complications of immune-mediated systemic inflammatory diseases.
Eur Heart J Acute Cardiovasc Care. 2023 Nov 16;12(11):792-801. doi: 10.1093/ehjacc/zuad096.
3
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease.
Nat Rev Rheumatol. 2023 Jul;19(7):417-428. doi: 10.1038/s41584-023-00969-7. Epub 2023 May 25.
4
Positron Emission Tomography Imaging in Vasculitis.
Cardiol Clin. 2023 May;41(2):251-265. doi: 10.1016/j.ccl.2023.01.012. Epub 2023 Feb 19.
5
Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study.
Radiology. 2023 May;307(3):e222052. doi: 10.1148/radiol.222052. Epub 2023 Feb 28.
6
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.
J Am Coll Cardiol. 2023 Jan 31;81(4):336-354. doi: 10.1016/j.jacc.2022.10.034.
7
Quantitative Echocardiographic Assessment and Optimal Criteria for Early Intervention in Asymptomatic Tricuspid Regurgitation.
JACC Cardiovasc Imaging. 2023 Jan;16(1):13-24. doi: 10.1016/j.jcmg.2022.08.004. Epub 2022 Oct 19.
8
Stress Echocardiographic Prediction of Emerging Pulmonary Vascular Disease in Systemic Sclerosis.
J Am Soc Echocardiogr. 2023 Feb;36(2):259-261. doi: 10.1016/j.echo.2022.10.006. Epub 2022 Oct 13.
9
Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
Am J Respir Crit Care Med. 2023 Feb 1;207(3):312-322. doi: 10.1164/rccm.202204-0731OC.
10
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
Zotero 插件